Subscribe
  • Home
  • Issues
    • Online First
    • Latest Issue
    • Issue Archive
    • Special Issues
  • Browse By Topic
    • Personalized Medicine
    • Economics & Value
    • FDA Approvals, News & Updates
    • COVID-19
    • Cholangiocarcinoma
    • View All Topics ›
  • Conference Correspondent
    • ESMO 2025 - Wrap-Up: Triple-Negative Breast Cancer
    • ASCO 2025 - Wrap-Up: Triple-Negative Breast Cancer
  • Web Exclusives
    • Web Exclusive Articles
    • Videos
    • Interview with the Innovators
    • Prostate Cancer Diagnostics Monthly Minutes
    • Webinars
    • Quick Quiz
    • Press Releases
  • Association for Value-Based Cancer Care
  • VBCM
  • Value-Based Care in Myeloma

Lynne Lederman, PhD, Medical Writer

Authored Articles

Ponatinib: New Option for the Treatment of Adults with CML or Ph+ ALL that Is Resistant or Intolerant to Previous Therapy with Tyrosine Kinase Inhibitors
Lynne Lederman, PhD, Medical Writer
Drug Updates
February 2013, Vol 4, No 2
Read Article
Ziv-Aflibercept: A New Option for the Treatment of Patients with Metastatic Colorectal Cancer Resistant to or Progressing After an Oxaliplatin-Containing Regimen
Lynne Lederman, PhD, Medical Writer
Drug Updates
January 2013, Vol 4, No 1
Read Article
Oprozomib Shows Promise in Hematologic Malignancies
Lynne Lederman, PhD, Medical Writer
ASH 2013 Annual Meeting
January 2013, Vol 4, No 1
Read Article
Abraxane Receives New Indication for Locally Advanced or Metastatic Non–Small-Cell Lung Cancer, in Combination with Carboplatin, in Patients Who Are Not Candidates for Curative Surgery or Radiation Therapy
Lynne Lederman, PhD, Medical Writer
Drug Updates
November 2012, Vol 3, No 8
Read Article
Carfilzomib a New Option for the Treatment of Patients with Relapsed, Refractory Multiple Myeloma Previously Treated with Bortezomib and an Immunomodulatory Agent
Lynne Lederman, PhD, Medical Writer
Drug Updates
September 2012, Vol 3, No 6
Read Article

Top Trending Articles

1.
Immunotherapy Helps Navy Veteran Beat Stage 4 Lung Cancer
2.
HOPA Highlights: What's New in 2025?
3.
Peer Navigation Intervention Aims to Boost Childhood Cancer Clinical Trial Participation
  • Home
  • Issues
    • Online First
    • Latest Issue
    • Issue Archive
    • Special Issues
  • Browse By Topic
    • Personalized Medicine
    • Economics & Value
    • FDA Approvals, News & Updates
    • COVID-19
    • Cholangiocarcinoma
    • View All Topics ›
  • Conference Correspondent
    • ESMO 2025 - Wrap-Up: Triple-Negative Breast Cancer
    • ASCO 2025 - Wrap-Up: Triple-Negative Breast Cancer
  • Web Exclusives
    • Web Exclusive Articles
    • Videos
    • Interview with the Innovators
    • Prostate Cancer Diagnostics Monthly Minutes
    • Webinars
    • Quick Quiz
    • Press Releases
  • Association for Value-Based Cancer Care
  • VBCM
  • Value-Based Care in Myeloma
Subscribe

Stay In The Know

Stay up to date on the matters of value in cancer by signing up for the free, bi-monthly VBCC print publication and VBCC weekly e‑newsletter.

Subscribe
  • About
  • About VBCC
  • Mission Statement
  • Advertising
  • Contact
  • Contribute
  • Submit a Manuscript
  • Editorial / Publishing Policies
  • Author Guidelines
  • Publications
  • Value-Based Cancer Care
  • Value-Based Care in Myeloma
  • Cholangiocarcinoma News
Amplity
© Amplity, Inc. All Rights Reserved. Privacy Policy.

We Value Your Feedback! Tell Us How You Consume Content

Your feedback will help us tailor our content to better meet your needs and preferences.

*First Name
*Last Name
*Email
*What's your favorite format for experiencing our content?